Michael J. Borowitz incorporates Computational biology and Genomics in his research. His multidisciplinary approach integrates Genomics and Computational biology in his work. Michael J. Borowitz integrates Bioinformatics with Mutation in his research. In his works, he undertakes multidisciplinary study on Mutation and Bioinformatics. His research on Cancer research often connects related areas such as Myeloid. His work on Cancer research expands to the thematically related Myeloid. Many of his studies on Genetics apply to Transcriptome as well. Transcriptome and Exome are two areas of study in which he engages in interdisciplinary research. He integrates Exome and Gene expression in his research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber;Attilio Orazi;Robert Hasserjian;Jürgen Thiele.
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman;Jüergen Thiele;Daniel A. Arber;Richard D. Brunning.
Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
Charles G Mullighan;Xiaoping Su;Jinghui Zhang;Ina Radtke.
The New England Journal of Medicine (2009)
Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation
Stephen J. Brandt;William P. Peters;Susan K. Atwater;Joanne Kurtzberg.
The New England Journal of Medicine (1988)
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.
Michael J. Borowitz;Meenakshi Devidas;Stephen P. Hunger;W. Paul Bowman;W. Paul Bowman.
Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
Kirk R. Schultz;W. Paul Bowman;Alexander Aledo;William B. Slayton.
Journal of Clinical Oncology (2009)
The genomic landscape of hypodiploid acute lymphoblastic leukemia
Linda Holmfeldt;Lei Wei;Ernesto Diaz-Flores;Michael Walsh.
Nature Genetics (2013)
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)
Kirk R. Schultz;D. Jeanette Pullen;Harland N. Sather;Jonathan J. Shuster.
Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.
Richard C. Harvey;Richard C. Harvey;Charles G. Mullighan;Xuefei Wang;Kevin K. Dobbin.
Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry.
Michael J. Borowitz;Fiona E. Craig;Joseph A. DiGiuseppe;Andrea J. Illingworth.
Cytometry Part B-clinical Cytometry (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: